• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail

Delta Airlines, Inc 02-Jul-03

Department of Health and Human Services' logo

Public Health Service
Food and Drug Administration

  Detroit District
300 River Place
Suite 5900
Detroit, MI 48207
Telephone: 313-393-8100
FAX 313-393-8139



July 2, 2003

Mr. Leo Mullins
President and CEO
Defta Air Lines, Inc.
1030 Delta Boulevard
Atlanta,GA 30320

Dear Mr. Mullins:

On June 11-12, 2003, Food and Drug Administration investigators conducted an inspection of your airline point and service area located at [redacted]. The inspection found significant potable water backflow deficiencies as well as poor employee practices and insanitary conditions, which is a violation of the Public Health Service Act and Title 21 Code of Federal Regulations, Parts 1240 and 1250 (The Control of Communicable Disease and Interstate Conveyance Sanitation). These deficiencies include:

1. The potable water system was not protected against backflow, in violation of 21 C.F.R. 1250.82(e). Specifically, there was no backflow prevention device on the potable water supply system to prevent contamination of potable water due to accidental misuse of the hose.

2. Failure to maintain and operate service area hoses and equipment in such a manner as to prevent contamination of drinking water, in violation of 21 C.F.R. 1250.67(a). Specifically, the potable water hose was misused when servicing employees of another company were allowed to place the hose in the floor drain and used it for flushing purposes during airport maintenance of clogged drains. In addition, potable water and lavatory carts and lavatory trucks were stored adjacent to one another on the ramp; the hose used to mix and fill deodorizer in the lavatory cart and truck was housed in the same room as the potable water source; the hose used for de-icing aircraft was housed in the same room as the potable water source; during winter months the lavatory truck is stored in the same room as the potable water source; the employee smoking and break room is located in the same room as the potable water source; and the room housing the potable water source was noted to be unkempt and soiled with miscellaneous debris, standing water, and cracked flooring.

The above objectionable conditions were pointed out and explained to [redacted] Station Manager - Detroit Station. A written list of objectionable conditions was issued to [redacted] immediately after the inspection.

As an operator of interstate aircraft conveyances, you are subject to the provisions of the Public Health Service Act, and Title 21 Code of Federal Regulations, Parts 1240 and 1250 (The Control of Communicable Disease and lnterstate Conveyance Sanitation). Because of the insanitary conditions observed, your airline potable water facility is now classified as “Provisional," pursuant to FDA’s authority codified at 21 C.F.R. 1240.83.

A reinspection will be conducted to determine if the objectionable conditions have been corrected. lf the reinspection reveals adequate corrections have not been made, your facility will be reclassified as "Not Approved". Potable water facllitles classified “Not Approved" cannot be used by an interstate aircraft conveyance company. Airline companies engaged in interstate commerce may obtain potable water only from facilities approved by tha U.S. Food and Drug Administration. We request that you take prompt action to correct this situation. Failure to do so may result in further enforcement action.

Please advise us in writing within fifteen (15) working days of the receipt of this letter of the actions you have taken to bring your firm into compliance with the law.. Your response should include an explanation of each step being taken to correct the violations and prevent their recurrence. lf corrective action cannot be completed within 30 working days, state the reason for the delay and the date by which the corretions will be completed. Include copies of any available documentation demonstrating that corrections have been made.

Your reply should be directed to the attention of Judith A. Jankowski, Compliance Officer, U.S. Food and Drug Administration, 300 River Place, Suite 5900, Detroit, Michigan 48207 (313) 393-8125.

Sincerely your,
David M. Daszubski
for Joann M. Givens
District Director
Detroit District Office